Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
CanadaIPO:
10 January 2007Next earnings report:
14 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | 72 min agoDividend
Analysts recommendations
Institutional Ownership
PMN Latest News
TORONTO, Ontario and CAMBRIDGE, Massachusetts, Sept. 06, 2023 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), today announced that Gail Farfel, Ph.D., Chief Executive Officer and Larry Altstiel, M.D., Ph.D., Chief Medical Officer of ProMIS Neurosciences, will present at the upcoming H.C. Wainwright 25th Annual Global Investment Conference on Tuesday, September 12, 2023 at 4:30 p.m. ET in New York, NY.
What type of business is ProMIS Neurosciences?
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
What sector is ProMIS Neurosciences in?
ProMIS Neurosciences is in the Healthcare sector
What industry is ProMIS Neurosciences in?
ProMIS Neurosciences is in the Biotechnology industry
What country is ProMIS Neurosciences from?
ProMIS Neurosciences is headquartered in Canada
When did ProMIS Neurosciences go public?
ProMIS Neurosciences initial public offering (IPO) was on 10 January 2007
What is ProMIS Neurosciences website?
https://www.promisneurosciences.com
Is ProMIS Neurosciences in the S&P 500?
No, ProMIS Neurosciences is not included in the S&P 500 index
Is ProMIS Neurosciences in the NASDAQ 100?
No, ProMIS Neurosciences is not included in the NASDAQ 100 index
Is ProMIS Neurosciences in the Dow Jones?
No, ProMIS Neurosciences is not included in the Dow Jones index
When does ProMIS Neurosciences report earnings?
The next expected earnings date for ProMIS Neurosciences is 14 August 2024